Immunogen, Inc. (IMGN) Posts Q1 Loss of $0.26, Sales Fall Short
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q1 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $5.61 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
